Integrated Core Strategies (US) LLC 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-04 4:07 pm Sale |
2024-09-30 | 13G | Sutro Biopharma, Inc. STRO |
Integrated Core Strategies (US) LLC | 2,031,745 2.500% |
-1,420,080 (-41.14%) |
Filing |
| 2024-01-17 4:54 pm Purchase |
2024-01-10 | 13G | Sutro Biopharma, Inc. STRO |
Integrated Core Strategies (US) LLC | 3,451,825 5.700% |
3,451,825 (New Position) |
Filing |